SC
PASG icon

Shay Capital’s Passage Bio PASG Stock Holding History

Shay Capital’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,336
Closed -$51.8K – 402
2025
Q1 		$51.8K Sell
7,336
-3,927
-35% -$42.5K 0.01% 287
2024
Q4 		$128K Buy
11,263
+6,650
+144% +$86.6K 0.02% 269
2024
Q3 		$64.6K Buy
+4,613
New +$73.5K 0.01% 284

Other funds holding PASG

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Shay Capital's PASG Position: Q2 2025 in Review

Shay Capital sold out of Passage Bio (PASG) in Q2 2025, closing a stake of 7,336 shares — an estimated $51.8K sold.

Shay Capital first reported a position in PASG in Q3 2024 and held it in 3 quarters. The position peaked at $128K in Q4 2024. 39 funds tracked by Wall St. Rank hold PASG as of Q2 2025.

  • Shay Capital reported no remaining Passage Bio position as of Q2 2025 after selling out during the quarter.
  • Shay Capital sold 7,336 Passage Bio shares in Q2 2025, an estimated $51.8K.
  • Shay Capital first reported a position in Passage Bio in Q3 2024 and held it in 3 quarters.
  • Shay Capital's Passage Bio position peaked at $128K in Q4 2024.
  • 39 funds tracked by Wall St. Rank held Passage Bio as of Q2 2025.

Based on Shay Capital's 13F filing for Q2 2025, filed 14 Aug 2025.